Browse 68 market data tables and 88 figures spread through 150 pages and in-depth TOC on “Metabolic Testing Market"
Early buyers will receive 10% customization on this report
According to estimates from the World Bank, the global healthcare spending increased from $3,770.14 billion in 2003 to $7,163.64 billion in 2012, at a CAGR of 7.39%. During this period, the public healthcare spending increased at a CAGR of 7.82%, from $2,182.47 billion in 2003 to $4,285.10 billion in 2012. On the other hand, the global population increased at a CAGR of 1.19%, from 6,302 million in 2003 to 7,008 million in 2012. The per capita healthcare spending also increased from $598 in 2003 to $1,022 in 2012, at a CAGR of 6.13%. Increase in healthcare expenditure is an important growth driver for the metabolic testing market.
Inquire for Report: http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=149228862
The global metabolic testing market is expected to reach $475.75 million by 2019 from $332.78 million in 2014, growing at a CAGR of 7.41% from 2014 to 2019. Rising prevalence of lifestyle diseases is the primary growth driver for this market during the forecast period (2014–2019). Moreover, technological advancements and increasing healthcare expenditure are also expected to drive market growth. However, high cost of equipment and software and reimbursement may hinder the growth of this market.
The global metabolic testing market is segmented on the basis of products, technologies, and applications. CPET system was the largest product segment while VO2 max analysis was the largest technology segment in 2014. VO2 max assessment is an important parameter for metabolic testing and is one of the most widely prescribed metabolic tests for athletes, healthy individuals, as well as patients. The lifestyle diseases application segment accounted for the largest share of the global metabolic testing market owing to the rising prevalence of lifestyle diseases such as cardiovascular diseases, diabetes, and obesity.
Get PDF Brochure: http://www.marketsandmarkets.com/pdfdownload.asp?id=149228862
The major players of this market are CareFusion Corporation (U.S.), MGC Diagnostics Corporation (U.S.), COSMED (Italy), CORTEX Biophysik GmbH (Germany), Geratherm Medical AG (Germany), General Electric Company (U.S.), OSI Systems, Inc. (U.S.), KORR Medical Technologies, Inc. (U.S.), AEI Technologies, Inc. (U.S.), Parvo Medics (U.S.), and Microlife Medical Home Solutions, Inc. (U.S.).
MarketsandMarkets is world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.
M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
North - Dominion Plaza,
17304 Preston Road,
Suite 800, Dallas, TX 75252